Furthermore, in human B lymphocytes, intracellular delivery of the HHph-GILZ peptide inhibited cell proliferation in vitro, explaining the observation of reduced GILZ in B cells of systemic lupus erythematosus patients and lupus-prone mice (85). This evidence concerns the gene TSC22D3 and systemic lupus erythematosus.